Current Gene Therapy

Meet Our Editorial Board Member
pp. 259-260(2)
Author: Simonato, Michele

Editorial: CRISPR Medicine: From Bench to Bedside
pp. 261-262(2)
Author: Dellaire, Graham

CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo
pp. 263-274(12)
Authors: Salsman, Jayme; Masson, Jean-Yves; Orthwein, Alexandre; Dellaire, Graham

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery
pp. 275-285(11)
Authors: Robert, Francis; Huang, Sidong; Pelletier, Jerry

New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish
pp. 286-300(15)
Authors: Prykhozhij, Sergey V.; Caceres, Lucia; Berman, Jason N.

Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy
pp. 301-308(8)
Authors: Wong, Tatianna W. Y.; Cohn, Ronald D.

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?
pp. 309-319(11)
Authors: Baylis, Francoise; McLeod, Marcus

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy
pp. 320-326(7)
Authors: Zhang, Yong; Tian, Zhen; Yuan, Jiajia; Liu, Chang; Liu, Hong l.; Ma, Si Qi; Li, Bin